Drug Effect: Clinical Trials

6 trials for Drug Effect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Drug Effect: new trials by email Literature Review of Drug Effect trials Research Report on Drug Effect

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
Flurbiprofen - Oral Soft Tissue Conditions, Drug Effect
Phase 4CompletedYuzuncu Yil University402023-10-262024-07-26
Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis
Cinacalcet - Drug Effect
Phase 4CompletedTanta University352023-08-052024-01-24
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Cyanocobalamin, Dulaglutide - Glucose Intolerance, Overweight and Obesity
Phase 4CompletedThe University of Texas Health Science Center, Houston232020-05-152024-12-05
Comparison of the Efficacy and Safety of Two Homologous Active Principles for Local Dental Anesthesia
Articaine / EPINEPHrine Cartridge - Drug Effect, Tooth Extraction
Phase 4CompletedUniversidad de Antioquia1792018-09-042021-05-12
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
Liposomal bupivacaine injection, Bupivacaine indwelling catheter - Drug Effect, Rib Fractures
Phase 4CompletedDenver Health and Hospital Authority362017-10-052021-09-29
Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia
Levobupivacaine (as Levobupivacaine Hydrochloride) 75 Mg/10 mL Solution for Injection Ampoule, Bupivacaine/Dextrose - Outpatients, General Surgery
Phase 4CompletedGazi University602007-11-212020-01-29

Narrower conditions

Glucose Intolerance (1)  ·  Neuralgia (1)  ·  Obesity (1)  ·  Opioid-Related Disorders (1)  ·  Overweight (1)  ·  Pain (1)  ·  Pneumonia (1)  ·  Prediabetic State (1)  ·  Rectal Diseases (1)  ·  Rib Fractures (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Body Weight (1)  ·  Chemically-Induced Disorders (1)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Fractures, Bone (1)  ·  Gastrointestinal Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperglycemia (1)  ·  Infections (1)  ·  Intestinal Diseases (1)  ·  Lung Diseases (1)  ·  Mental Disorders (1)

Interventions

Bupivacaine (1)  ·  Carticaine (1)  ·  Cinacalcet (1)  ·  Flurbiprofen (1)  ·  Glucose (1)  ·  Levobupivacaine (1)  ·  Solutions (1)  ·  Vitamin B 12 (1)  ·  dulaglutide (1)

Sponsors

Denver Health and Hospital Authority (1)  ·  Gazi University (1)  ·  Tanta University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Universidad de Antioquia (1)  ·  Yuzuncu Yil University (1)

Countries

United States (2)  ·  Colombia (1)  ·  Egypt (1)  ·  Turkey (Türkiye) (1)

Top investigators

Absalon D Gutierrez, MD (1)  ·  Cennet N Eroglu, DDS,PhD (1)  ·  Fabian Jaimes, MD, PhD (1)  ·  Fredric Pieracci, MD MPH (1)  ·  Sara Mabrouk Mohamed Elghoul, MD (1)

Results publications

PMID 10028738, PMID 10832257, PMID 12366885, PMID 15966499, PMID 17082283, PMID 18762633, PMID 20006669, PMID 21772732, PMID 22915899, PMID 26868800, PMID 33951024, PMID 34195402

NIH funding

R21DK122234 (1)